Bartosz Chmielowski
- Oncology top 0.5%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 1%
- Immunology top 1%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Antoni RibasJohn A. GlaspyRichard C. KoyaThinle ChodonJeffrey A. SosmanRoger S. LoJeffrey S. WeberElizabeth Seja
- Topics
- Cancer Immunotherapy and Biomarkers (50 papers)CAR-T cell therapy research (45 papers)Sarcoma Diagnosis and Treatment (40 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Bartosz Chmielowski
172 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 4.4k
- Molecular Biology 2.6k
- Pulmonary and Respiratory Medicine 1.8k
- Immunology 1.8k
- Pathology and Forensic Medicine 538
Countries citing papers authored by Bartosz Chmielowski
This map shows the geographic impact of Bartosz Chmielowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bartosz Chmielowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bartosz Chmielowski more than expected).
Fields of papers citing papers by Bartosz Chmielowski
This network shows the impact of papers produced by Bartosz Chmielowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bartosz Chmielowski. The network helps show where Bartosz Chmielowski may publish in the future.
Co-authorship network of co-authors of Bartosz Chmielowski
This figure shows the co-authorship network connecting the top 25 collaborators of Bartosz Chmielowski. A scholar is included among the top collaborators of Bartosz Chmielowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bartosz Chmielowski. Bartosz Chmielowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 48 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 13 | |
| 10 | 77 | |
| 11 | 15 | |
| 12 | 3 | |
| 13 | 302 | |
| 14 | Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapybreakdown → | 715 |
| 15 | 112 | |
| 16 | 27 | |
| 17 | 75 | |
| 18 | 60 | |
| 19 | 120 | |
| 20 | 163 |
About Bartosz Chmielowski
Bartosz Chmielowski is a scholar working on Oncology, Biotechnology and Immunology, having authored 180 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (50 papers), CAR-T cell therapy research (45 papers) and Sarcoma Diagnosis and Treatment (40 papers). The work is most often cited by research in Oncology (4.4k citations), Immunology (1.8k citations) and Pulmonary and Respiratory Medicine (1.8k citations). Bartosz Chmielowski has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Antoni Ribas, John A. Glaspy, Richard C. Koya, Thinle Chodon, Jeffrey A. Sosman, Roger S. Lo, Jeffrey S. Weber, Elizabeth Seja, Douglas B. Johnson and Richard Kefford. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.